Umeå University's logo

umu.sePublications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Overloading of stable and exclusion of unstable human superoxide dismutase-1 variants in mitochondria of murine amyotrophic lateral sclerosis models
Umeå University, Faculty of Medicine, Medical Biosciences, Clinical chemistry.
Umeå University, Faculty of Medicine, Medical Biosciences, Clinical chemistry.
Umeå University, Faculty of Medicine, Medical Biosciences, Pathology.
Umeå University, Faculty of Medicine, Pharmacology and Clinical Neuroscience, Neurology.
Show others and affiliations
2006 (English)In: Journal of Neuroscience, ISSN 0270-6474, E-ISSN 1529-2401, Vol. 26, no 16, p. 4147-4154Article in journal (Refereed) Published
Place, publisher, year, edition, pages
2006. Vol. 26, no 16, p. 4147-4154
Keywords [en]
Amyotrophic Lateral Sclerosis/*enzymology/genetics, Animals, Disease Models; Animal, Enzyme Stability/genetics, Humans, Mice, Mice; Transgenic, Mitochondria/*enzymology/genetics, Mutation, Spinal Cord/enzymology, Superoxide Dismutase/*biosynthesis/genetics, Variation (Genetics)
Identifiers
URN: urn:nbn:se:umu:diva-15270DOI: 10.1523/JNEUROSCI.5461-05.2006PubMedID: 16624935Scopus ID: 2-s2.0-33646452761OAI: oai:DiVA.org:umu-15270DiVA, id: diva2:154942
Available from: 2008-01-11 Created: 2008-01-11 Last updated: 2023-03-24Bibliographically approved
In thesis
1. Mutant superoxide dismutase-1-caused pathogenesis in amyotrophic lateral sclerosis
Open this publication in new window or tab >>Mutant superoxide dismutase-1-caused pathogenesis in amyotrophic lateral sclerosis
2010 (English)Doctoral thesis, comprehensive summary (Other academic)
Abstract [en]

Amyotrophic lateral sclerosis (ALS) is a devastating disease that affects people in their late mid-life, with fatal outcome usually within a few years. The progressive degeneration of neurons responsible for muscle movement (motor neurons) throughout the central nervous system (CNS) leads to muscle wasting and paralysis, and eventually affects respiratory function. Most cases have no familial background (sporadic) whereas about 10% of cases have relatives affected by the disease. A substantial number of familial cases are caused by mutations in the gene encoding superoxide dismutase-1 (SOD1). Since the initial discovery of this relationship about 17 years ago, numerous workers have tried to identify the pathogenicity of mutant SOD1 but without any final agreement or consensus regarding mechanism. The experiments in this thesis have been aimed at finding common pathogenic mechanisms by analyzing transgenic mouse models expressing mutant SOD1s with widely different properties.

    Mitochondrial pathology and dysfunction have been reported in both ALS patients and murine models. We used density gradient ultracentrifugation for comparison of mitochondrial partitioning of SOD1 in our transgenic models. It was found that models with high levels of mutant protein, overloaded mitochondria with high levels of SOD1-protein whereas models with wild type-like levels of mutant protein did not. No significant association of the truncation mutant G127X with mitochondria was found. Thus, if mitochondrial dysfunction and pathology are fundamental for ALS pathogenesis this is unlikely to be caused by physical association of mutant SOD1 with mitochondria.

    Density gradient ultracentrifugation was used to study SOD1 inclusions in tissues from an ALS patient with a mutant SOD1 (G127X). We found large amounts in the ventral horns of the spinal cord but also in the liver and kidney, although at lower levels. This showed that such signs of the disease can also be found outside the CNS.

    This method was used further to characterize SOD1 inclusions with regard to the properties of mutant SOD1 and the presence of other proteins. The inclusions were found to be complex detergent-sensitive structures with mutant SOD1 reduced at disulfide C57-C146 being the major inclusion protein, constituting at least 50% of the protein content. Ten co-aggregating proteins were isolated, some of which were already known to be present in cellular inclusions. Of great interest was the presence of several proteins that normally reside in the endoplasmic reticulum (ER), which is in accordance with recent data suggesting that the unfolded protein response (UPR) has a role in ALS.

    To obtain unbiased information on the pathogenesis of mutant SOD1, we performed a total proteome study on spinal cords from ALS transgenic mice. By multivariate analysis of the 1,800 protein spots detected, 420 (23%) were found to significantly contribute to the difference between transgenic and control mice. From 53 proteins finally identified, we found pathways such as mitochondrial function, oxidative stress, and protein degradation to be affected by the disease. We also identified a previously uncharacterized covalent SOD1 dimer.

   In conclusion, the work described in this thesis suggests that mutant SOD1 affects the function of mitochondria, but not mainly through direct accumulation of SOD1 protein. It also suggests that SOD1 inclusions, present in both the CNS and peripheral tissues, mainly consist of SOD1 but they also trap proteins involved in the UPR. This might be deleterious as motor neurons, unable to renew themselves, are dependent on proper protein folding and degradation.

Place, publisher, year, edition, pages
Umeå: Umeå university, 2010. p. 89
Series
Umeå University medical dissertations, ISSN 0346-6612 ; 1285
Keywords
ALS, SOD1, mitochondria, proteome, transgenic mice, inclusion
National Category
Other Clinical Medicine
Research subject
Biochemistry; Neurology; Clinical Chemistry; Pathology
Identifiers
urn:nbn:se:umu:diva-31116 (URN)978-91-7264-838-8 (ISBN)
Public defence
2010-02-26, Betula, NUS, 90185, Umeå, 10:00 (English)
Opponent
Supervisors
Available from: 2010-02-05 Created: 2010-01-29 Last updated: 2018-06-08Bibliographically approved

Open Access in DiVA

No full text in DiVA

Other links

Publisher's full textPubMedScopushttp://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Retrieve&list_uids=16624935&dopt=Citation

Authority records

Bergemalm, DanielGraffmo, Karin SBrännström, Thomas

Search in DiVA

By author/editor
Bergemalm, DanielGraffmo, Karin SBrännström, Thomas
By organisation
Clinical chemistryPathologyNeurology
In the same journal
Journal of Neuroscience

Search outside of DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 566 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf